earnings
confidence high
sentiment positive
materiality 0.70
CareDx prelim FY2023 revenue $279-280M, above high end of guidance; Q4 patient volumes up 4% QoQ
CareDx, Inc.
2023-FY EPS reported
-$3.54
revenue$280,324,000
- Full-year revenue expected $279-280M, exceeding $277M high-end guidance; FY2022 was $321.8M.
- Q4 testing-services revenue $46-47M vs $47.8M in Q3; patient results ~39,900, up 4% sequentially.
- Patient & Digital Solutions FY rev ~$37M (+29% YoY); Products ~$33.5M (+14% YoY).
- Repurchased 2.8M shares for $26M; cash & equivalents $235M with no debt.
- Fifth consecutive quarter of testing-services collections above 100% of revenue.